Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-05-08

Clinical Trial Update: The Clinical Trial of Chinese Herbal Medicine SaiLuoTong Capsule [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of SaiLuoTong Capsule for vascular dementia is being conducted by Shineway Pharmaceutical, with no results reported in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SaiLuoTong Capsule

Snippet

Sponsor: Shineway Pharmaceutical Co.,Ltd | Conditions: Vascular Dementia | Phase 2 | Status: UNKNOWN